Ethical Nutraceuticals: Need of the hour Lakshmipriya Nair May 22, 2023 India Pharma Inc needs to arm itself with an evidence-based approach, significant investments and meaningful collaborations to…
Indoco receives EIR for its manufacturing facility in Goa (Plant I) EP News Bureau May 3, 2023 The receipt of the EIR with VAI status also signifies the imminent closeout of the Warning Letter issued by the USFDA in July 2019…
Indoco launches Brinzolamide Ophthalmic Suspension 1% in US by Teva Pharma EP News Bureau Mar 9, 2021 It is used to treat high pressure inside the eye due to ocular hypertension and open-angle glaucoma
Indoco gets USFDA approval for Olanzapine tablets EP News Bureau Aug 6, 2020 Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder
API barcoding Benefits and bottelenecks Usha Sharma Jul 29, 2019 Recently, the Union Health Ministry announced that the government will make it mandatory for all API packages to be barcoded and…
Aditi Kare Panandikar, Managing Director, Indoco Remedies Usha Sharma Jul 29, 2019 APIs are critical components that make drug formulations potent against diseases. Good quality of APIs is critical to the…
USFDA clears Indoco’s Goa Plant II and III EP News Bureau Jul 26, 2019 The inspection was held from 27th May, 2019 to 4th June, 2019, where the company had received four observations (483s)
Indoco Remedies gets warning letter from USFDA for oral dosages plant in Goa Press Trust of India Jul 15, 2019 The company has received a warning letter from the United States Food and Drug Administration (USFDA) as a result of the…
Indoco Remedies receives USFDA nod for solid dosages plant I in Goa Usha Sharma Mar 22, 2016 The plant has a capacity to manufacture 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and…
KM Kundnani College of Pharmacy celebrates 45th Annual Day EP News Bureau Feb 12, 2016 A slew of activities were held to commemmorate the event